Israeli startup RedC Biotech aims to replace donors with lab-grown blood from stem cells

RedC Biotech says its lab-grown blood could prevent the deaths of 2 million people a year, solving shortages that leave hospitals worldwide without safe, reliable supplies during emergencies, wars and disasters ================================================================== An Israeli biotech startup is developing technology it says could revolutionize the global blood supply by producing universal red blood cells from stem cells on an industrial scale. RedC Biotech, founded by Dr. Ari Gargir, is working to cultivate red blood cells in large bioreactors, potentially generating hundreds of transfusion-ready units at a time. The company’s goal is to provide a reliable and cost-effective supply of blood to...